MemorEM

· NeuroEM Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MemorEM, covering 2025-08-05 to 2025-08-05. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases [NA]